292 related articles for article (PubMed ID: 16160082)
1. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
2. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.
Holland PR; Akerman S; Goadsby PJ
Eur J Neurosci; 2006 Nov; 24(10):2825-33. PubMed ID: 17156207
[TBL] [Abstract][Full Text] [Related]
3. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
Akerman S; Goadsby PJ
Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
[TBL] [Abstract][Full Text] [Related]
4. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.
Akerman S; Kaube H; Goadsby PJ
Br J Pharmacol; 2003 Oct; 140(4):718-24. PubMed ID: 14534154
[TBL] [Abstract][Full Text] [Related]
5. Neurogenic vasodilation of dural blood vessels is not mediated by cholinergic transmission in the anaesthetised rat.
Kowacs F; Williamson DJ; Goadsby PJ
Eur J Pharmacol; 2004 Jun; 493(1-3):133-7. PubMed ID: 15189774
[TBL] [Abstract][Full Text] [Related]
6. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.
Akerman S; Williamson DJ; Goadsby PJ
Br J Pharmacol; 2003 Oct; 140(3):558-66. PubMed ID: 12970082
[TBL] [Abstract][Full Text] [Related]
7. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
[TBL] [Abstract][Full Text] [Related]
8. Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation.
Andreou AP; Holland PR; Goadsby PJ
Br J Pharmacol; 2009 Jun; 157(3):464-73. PubMed ID: 19309356
[TBL] [Abstract][Full Text] [Related]
9. Effect of two novel CGRP-binding compounds in a closed cranial window rat model.
Juhl L; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2007 Jul; 567(1-2):117-24. PubMed ID: 17477918
[TBL] [Abstract][Full Text] [Related]
10. The role of dopamine in a model of trigeminovascular nociception.
Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):162-9. PubMed ID: 15778266
[TBL] [Abstract][Full Text] [Related]
11. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin.
Gupta S; Villalón CM; Mehrotra S; de Vries R; Garrelds IM; Saxena PR; MaassenVanDenbrink A
Headache; 2007 Feb; 47(2):225-35. PubMed ID: 17300362
[TBL] [Abstract][Full Text] [Related]
12. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.
Akerman S; Holland PR; Lasalandra MP; Goadsby PJ
Headache; 2009 Sep; 49(8):1131-43. PubMed ID: 19719541
[TBL] [Abstract][Full Text] [Related]
13. Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery.
Bhatt DK; Ploug KB; Ramachandran R; Olesen J; Gupta S
Headache; 2010 Jun; 50(6):1017-30. PubMed ID: 20487037
[TBL] [Abstract][Full Text] [Related]
14. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
15. Neurogenic inflammation in the context of migraine.
Williamson DJ; Hargreaves RJ
Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
[TBL] [Abstract][Full Text] [Related]
16. The role of histamine in dural vessel dilation.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Brain Res; 2002 Nov; 956(1):96-102. PubMed ID: 12426051
[TBL] [Abstract][Full Text] [Related]
17. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
Williamson DJ; Shepheard SL; Hill RG; Hargreaves RJ
Eur J Pharmacol; 1997 Jun; 328(1):61-4. PubMed ID: 9203569
[TBL] [Abstract][Full Text] [Related]
18. Study of an adenosine A1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat.
Honey AC; Bland-Ward PA; Connor HE; Feniuk W; Humphrey PP
Cephalalgia; 2002 May; 22(4):260-4. PubMed ID: 12100087
[TBL] [Abstract][Full Text] [Related]
19. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
20. Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats.
Williamson DJ; Shepheard SL; Cook DA; Hargreaves RJ; Hill RG; Cumberbatch MJ
Br J Pharmacol; 2001 Jul; 133(6):807-14. PubMed ID: 11454653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
